Selank vs Semax: Comparing Nootropic Peptides
Introduction
Selank and Semax are two synthetic peptides that have garnered significant attention in nootropic and neurological research. Both were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, and both have been approved for clinical use in Russia -- Selank as an anxiolytic and Semax as a nootropic and neuroprotective agent. Despite their shared origin, these peptides differ substantially in their structures, mechanisms of action, and primary research applications. Understanding these differences is essential for researchers designing studies in neuroscience and cognitive research.
What Is Selank?
Selank (TP-7) is a synthetic heptapeptide derived from the endogenous immunomodulatory peptide tuftsin (threonyl-lysyl-prolyl-arginine), with the addition of a stabilizing Pro-Gly-Pro sequence. The full sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro. Tuftsin, its parent compound, is a naturally occurring tetrapeptide produced by enzymatic cleavage of the Fc region of immunoglobulin G (IgG) in the spleen.
### Selank Mechanism of Action
Selank's pharmacological profile is characterized by anxiolytic (anti-anxiety) and nootropic effects achieved through multiple neurochemical pathways:
- GABAergic modulation: Selank enhances the expression of GABA-A receptor subunits in the hippocampus and cortex, increasing inhibitory neurotransmission. This mechanism is thought to underlie its anxiolytic properties without the sedation, tolerance, or dependence associated with benzodiazepines (Seredenin et al., 2008).
- Monoamine modulation: Research shows Selank increases serotonin metabolism in the cortex and hippocampus. Kost et al. (2001) demonstrated that Selank influences the activity of carboxypeptidases that metabolize enkephalins, thereby modulating the opioid system indirectly.
- BDNF expression: Selank upregulates brain-derived neurotrophic factor (BDNF) and its receptor TrkB in the hippocampus, potentially supporting neuroplasticity and memory consolidation.
- Immune modulation: As a tuftsin derivative, Selank retains immunomodulatory properties, influencing the expression of interleukins (IL-6, IL-10) and interferons. This dual neuroimmune profile is relatively unique among nootropic peptides.
What Is Semax?
Semax is a synthetic heptapeptide based on the ACTH(4-7) fragment (Met-Glu-His-Phe) with the addition of a C-terminal Pro-Gly-Pro stabilizing sequence, yielding the full sequence Met-Glu-His-Phe-Pro-Gly-Pro. The ACTH(4-7) fragment represents the portion of adrenocorticotropic hormone (ACTH) associated with cognitive and neurotrophic effects, stripped of the adrenal stimulatory activity present in the full ACTH molecule.
### Semax Mechanism of Action
Semax operates through distinct neurochemical pathways that produce predominantly cognitive-enhancing and neuroprotective effects:
- BDNF and NGF upregulation: Semax is one of the most potent known stimulators of BDNF and nerve growth factor (NGF) expression. Dolotov et al. (2006) demonstrated significant increases in BDNF mRNA in the rat hippocampus and cortex following Semax administration, with effects persisting for hours after a single dose.
- Dopaminergic and serotonergic enhancement: Semax modulates dopamine and serotonin turnover in the mesolimbic system, contributing to improvements in attention, motivation, and learning observed in preclinical studies.
- Neuroprotection: Semax has demonstrated neuroprotective effects in models of ischemic stroke, reducing infarct volume and improving functional outcomes in rodent studies (Gusev et al., 2005). The mechanism involves anti-apoptotic signaling through the Bcl-2 pathway and reduction of oxidative stress.
- Gene expression: Transcriptomic studies have revealed that Semax modulates the expression of hundreds of genes involved in neurotrophic signaling, immune response, and vascular function in brain tissue.
Mechanism Comparison
| Feature | Selank | Semax | |---------|--------|-------| | Parent compound | Tuftsin (IgG-derived) | ACTH(4-7) fragment | | Primary action | Anxiolytic + nootropic | Nootropic + neuroprotective | | GABA modulation | Strong (GABA-A upregulation) | Minimal | | BDNF effects | Moderate upregulation | Strong upregulation | | Dopamine effects | Indirect (via enkephalin modulation) | Direct modulation | | Immune activity | Significant (tuftsin-derived) | Moderate | | Adrenal effects | None | None (ACTH fragment lacks adrenal stimulation) |
Preclinical Evidence
### Selank Studies
Preclinical research on Selank has demonstrated:
- Anxiety models: Selank produces anxiolytic effects in the elevated plus maze, open field test, and social interaction tests in rodents, comparable to diazepam but without motor impairment (Zozulya et al., 2001).
- Memory: Selank improves passive avoidance retention and spatial learning in Morris water maze tests.
- Stress resilience: Animals pre-treated with Selank show attenuated corticosterone responses to acute stress.
- Immune function: Selank normalizes cytokine profiles in immunosuppressed animal models.
### Semax Studies
Preclinical and clinical research on Semax has shown:
- Cognitive enhancement: Semax improves attention, memory consolidation, and learning speed in both animal models and human studies. Clinical studies in Russia demonstrated improved cognitive performance in patients with cognitive impairment (Ashmarin et al., 1997).
- Stroke recovery: Semax is approved in Russia for treatment of ischemic stroke, based on clinical data showing improved neurological outcomes when administered in the acute phase.
- Optic nerve damage: Studies have demonstrated neuroprotective effects of Semax on retinal ganglion cells in models of optic nerve injury.
- ADHD research: Preliminary studies have explored Semax in attention deficit models, showing improvements in sustained attention and impulsivity measures.
Research Applications
Selank and Semax serve different but complementary roles in neuroscience research:
- Selank is most appropriate for studies investigating anxiety, stress resilience, GABAergic modulation, neuroimmune interactions, and conditions where anxiolytic effects are the primary endpoint.
- Semax is better suited for studies focused on cognitive enhancement, neurotrophic factor expression, neuroprotection, stroke recovery, and attention/learning paradigms.
Some researchers investigate both peptides in combination protocols, leveraging Selank's anxiolytic profile alongside Semax's cognitive-enhancing properties. However, rigorous combination studies remain limited, and researchers should establish baseline responses to each peptide individually before exploring synergistic protocols.
Key Differences Summary
1. Origin: Selank derives from the immune system (tuftsin/IgG), while Semax derives from the endocrine system (ACTH). 2. Primary effect: Selank is primarily anxiolytic with secondary nootropic effects; Semax is primarily nootropic with secondary neuroprotective effects. 3. GABAergic activity: Selank has significant GABA-modulating properties; Semax does not substantially affect GABA systems. 4. Neurotrophic potency: Semax is a more potent stimulator of BDNF and NGF expression than Selank. 5. Clinical approval: Both are approved in Russia -- Selank for generalized anxiety, Semax for cognitive impairment and stroke.
Conclusion
Selank and Semax represent two distinct approaches to peptide-based neuromodulation, each with a well-characterized pharmacological profile supported by decades of Russian and international preclinical research. Selank offers a unique combination of anxiolytic and immunomodulatory properties rooted in its tuftsin origin, while Semax provides robust neurotrophic and cognitive-enhancing effects derived from its ACTH heritage. Researchers should select between these peptides based on their specific study endpoints, and both compounds merit continued investigation as tools for understanding neuroplasticity, stress resilience, and cognitive function.
Research Disclaimer: This article is intended for educational and informational purposes only. All compounds discussed are for laboratory research use only and are not intended for human consumption. Always consult relevant literature and comply with all applicable regulations when conducting research.